Robert Arch
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/03/2024
Profilo
Robert H.
Arch served as President, CEO & Non-Independent Director at OncoSec Medical, Inc. from 2022 to 2023.
Prior to that, he was Head-Research at Elpiscience Biopharma Ltd.
from 2019 to 2021 and Head-Liver Disease Department at China Novartis Institutes for BioMedical Research Co., Ltd.
from 2017 to 2019.
Arch holds a doctorate degree from Julius-Maximilians-Universität Würzburg.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 21/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Precedenti posizioni note di Robert Arch
| Società | Posizione | Fine |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Chief Executive Officer | 14/06/2023 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
| China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 01/10/2019 |
Formazione di Robert Arch
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| Aziende private | 2 |
|---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
| China Novartis Institutes for BioMedical Research Co., Ltd. |
- Borsa valori
- Insiders
- Robert Arch
